Enhancement of immunogenicity of tumour virus antigen by liposomes: the effect of lipid composition
- PMID: 3733150
- PMCID: PMC1453458
Enhancement of immunogenicity of tumour virus antigen by liposomes: the effect of lipid composition
Abstract
The secondary humoral response evoked in W/Fu rats by the weakly immunogenic soluble Gross cell surface antigen (GCSAa) extracted from the syngeneic (C58NT)D lymphoma can be enhanced when GCSAa is presented in liposomes, and this requires the antigen to be strongly associated with the phospholipid bilayers. In order to investigate further the role of the phospholipid microenvironment in the membrane presentation of this antigen, the relationship between the phospholipid composition and the immunogenic potency of GCSAa liposomes was explored. For a given neutral phospholipid component, optimal immunogenicity was obtained when 20% cholesterol was present and when a negatively charged phospholipid was included as a minor component. When phosphatidylcholines (PC) were used as the major neutral component, the immunogenicity of GCSAa liposomes from optimal for distearoyl PC (DSPC) decreased when decreasing the PC acyl chain length down to the background level for dilauroyl PC (DLPC). Similarly, the use of PC with acyl chain of increasing unsaturation was followed by a decline in the immunogenicity of the GCSAa liposomes up to the background level for dilinoleoyl PC (DLiPC). Replacing PC headgroups by phosphatidylethanolamine (PE) headgroups abolished the enhancing effect of the liposome presentation on GCSAa immunogenicity. Three groups of phospholipids unable to promote the expression of the GCSAa immunogenicity could be distinguished: the DLPC, DLiPC group, unable to prime the animals but, contrary to the soluble antigen, able to boost the animal after an appropriate priming with GCSAa-DSPC-liposomes, the dimyristoyl PE group, unable to prime or to boost and non-toxic in vitro for the macrophages, and the dipalmitoyl PE group, acutely toxic for macrophages.
Similar articles
-
Presentation of an MuLV-related tumour antigen in liposomes as a potent tertiary immunogen after adoptive transfer.Immunology. 1986 Feb;57(2):219-23. Immunology. 1986. PMID: 3949369 Free PMC article.
-
Impairment of immunogenicity by antigen presentation in liposomes made from dimyristoylphosphatidylethanolamine linked to the secretion of prostaglandins by macrophages.Eur J Immunol. 1987 Dec;17(12):1839-42. doi: 10.1002/eji.1830171225. Eur J Immunol. 1987. PMID: 3691627
-
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. V. Effect of membrane composition on humoral and cellular immunogenicity.Immunology. 1981 Nov;44(3):561-8. Immunology. 1981. PMID: 7033115 Free PMC article.
-
Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens.Biochim Biophys Acta. 1992 Dec 11;1113(3-4):307-22. doi: 10.1016/0304-4157(92)90004-t. Biochim Biophys Acta. 1992. PMID: 1450204 Review. No abstract available.
-
Antibodies to liposomes, phospholipids, and cholesterol: implications for autoimmunity, atherosclerosis, and aging.Prog Clin Biol Res. 1990;343:41-51. Prog Clin Biol Res. 1990. PMID: 2198584 Review. No abstract available.
Cited by
-
Synthetic macrophages: antigen presentation by liposomes bearing class II major histocompatibility complex (MHC) and membrane interleukin-1 (IL-1).J Clin Immunol. 1989 Sep;9(5):369-77. doi: 10.1007/BF00917101. J Clin Immunol. 1989. PMID: 2559926 No abstract available.
-
Immunogenicity of liposomes and iscoms containing the major outer membrane protein of Neisseria gonorrhoeae: influence of protein content and liposomal bilayer composition.Infect Immun. 1988 Jun;56(6):1661-4. doi: 10.1128/iai.56.6.1661-1664.1988. Infect Immun. 1988. PMID: 3131250 Free PMC article.
-
Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides.Vaccine. 2015 Feb 11;33(7):861-8. doi: 10.1016/j.vaccine.2014.12.045. Epub 2015 Jan 2. Vaccine. 2015. PMID: 25559188 Free PMC article.
-
Adjuvant effect of cationic liposomes for subunit influenza vaccine: influence of antigen loading method, cholesterol and immune modulators.Pharmaceutics. 2013 Jul 25;5(3):392-410. doi: 10.3390/pharmaceutics5030392. Pharmaceutics. 2013. PMID: 24300513 Free PMC article.
-
Antigen presentation by liposomes bearing class II MHC and membrane IL-1.Yale J Biol Med. 1990 Mar-Apr;63(2):95-107. Yale J Biol Med. 1990. PMID: 2399741 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical